Mental and Substance Use Disorders Prevalence Study (MDPS), United States, 2020-2022 (ICPSR 38953)
Version Date: Feb 12, 2024 View help for published
Principal Investigator(s): View help for Principal Investigator(s)
Heather Ringeisen, RTI International;
Mark J. Edlund, RTI International;
Heidi Guyer, RTI International;
Jill Dever, RTI International;
Dan Liao, RTI International;
Andy Peytchev, RTI International;
Christine Carr, RTI International;
Paul Geiger, RTI International;
Leyla Stambaugh, RTI International;
Tim Smith, RTI International;
Lisa B. Dixon, Columbia University; New York State Psychiatric Institute;
Mark Olfson, Columbia University; New York State Psychiatric Institute;
Scott Stroup, Columbia University; New York State Psychiatric Institute;
Thomas E. Smith, Columbia University; New York State Psychiatric Institute;
Michael B. First, Columbia University; New York State Psychiatric Institute;
Natalie Bareis, Columbia University; New York State Psychiatric Institute;
Lydia Chwastiak, University of Washington;
Maria Monroe-DeVita, University of Washington;
Mackenzie E. Tennison, University of Washington;
Katherine Winans, University of Washington;
Scott Graupensperger, University of Washington;
Marvin S. Swartz, Duke University Health System;
Jeffrey W. Swanson, Duke University Health System;
Allison G. Robertson, Duke University Health System;
Ronald C. Kessler, Harvard Medical School;
Robert D. Gibbons, University of Chicago;
Elizabeth Sinclair Hancq, Treatment Advocacy Center
https://doi.org/10.3886/ICPSR38953.v1
Version V1
Summary View help for Summary
The Mental and Substance Use Disorders Prevalence Study (MDPS) is a pilot program designed to estimate the prevalence of specific mental and substance use disorders among U.S. adults 18-65 years of age. The MDPS is also designed to estimate the percentage of individuals with these specific mental and substance use disorders who receive treatment. The study is funded by SAMHSA. To estimate the prevalence of specific mental and substance use disorders, the MDPS design addresses two gaps in prior general population survey efforts: (1) the exclusion of institutionalized populations at high risk for disorders, and (2) the reliance on nonclinical or screening scales to estimate mental and substance use disorders. The specific disorders of interest measured in the MDPS are past 12-month and lifetime schizophrenia spectrum disorders (defined as including schizophrenia, schizoaffective disorder, or schizophreniform), past 12-month bipolar I disorder, major depressive disorder (MDD), generalized anxiety disorder (GAD), posttraumatic stress disorder (PTSD), obsessive-compulsive disorder, anorexia nervosa, and past 12-month alcohol, opioid, cannabis, stimulant, and sedative/hypnotic/anxiolytic use disorders. The MDPS sample included individuals residing in the residential household population and in three non-household populations: state/federal prisons, state psychiatric hospitals, and homeless shelters. The MDPS also utilizes the Structured Clinical Interview for DSM-5 (SCID-5; First et al., 2015), delivered by trained mental health clinicians, which is the gold standard for mental and substance use disorder diagnostic assessment. The MDPS was a cooperative agreement between RTI International and Substance Abuse and Mental Health Services Administration (SAMHSA).
Citation View help for Citation
Export Citation:
Funding View help for Funding
Subject Terms View help for Subject Terms
Geographic Coverage View help for Geographic Coverage
Smallest Geographic Unit View help for Smallest Geographic Unit
Census region
Restrictions View help for Restrictions
This data collection may not be used for any purpose other than statistical reporting and analysis. Use of these data to learn the identity of any person or establishment is prohibited. To protect respondent privacy, the data files in this collection are restricted from general dissemination. To obtain these restricted files, researchers must agree to the terms and conditions of Restricted Data Use Agreement.
Distributor(s) View help for Distributor(s)
Time Period(s) View help for Time Period(s)
Date of Collection View help for Date of Collection
Data Collection Notes View help for Data Collection Notes
- For additional information on the Mental and Substance Use Disorders Prevalence Study, please visit the MDPS website.
-
Some documentation may reflect a previous list of principal investigators. For a full list of investigators, please see this study homepage.
Study Purpose View help for Study Purpose
Mental and substance use disorders are significant public health concerns that affect the lives of millions of Americans. The Mental and Substance Use Disorders Prevalence Study (MDPS) was designed to provide national statistics as to the prevalence of mental and substance use disorders among U.S. adults aged 18-65 years. The design of MDPS addresses two gaps in prior general population survey efforts: (1) the exclusion of institutionalized populations at high risk for disorders, and (2) the reliance on nonclinical or screening scales to estimate mental and substance use disorders.
Study Design View help for Study Design
The MDPS involved four population samples: adults aged 18-65 years in households, state/federal prisons, state psychiatric hospitals, and homeless shelters. The last three samples were targeted because of existing data that indicates prevalence of mental and substance use disorders is higher in non-households. MDPS employed a three-stage design. The first stage was a roster to establish eligibility. The second stage was a mental health screening questionnaire to select participants with higher likelihood of one or more disorders. The third stage was a clinical interview that included the Structured Clinical Interview for DSM-5 (SCID-5). The SCID-5 was used to determine the presence of each mental and substance use disorder of interest to MDPS.
Sample View help for Sample
The household sample was drawn via a multistage, clustered, and stratified area sampling scheme to form a nationally representative sample of adults. In the first stage, primary sampling units (PSUs) are defined as counties or groups of counties for those with small populations. One hundred PSUs were randomly selected based on size measure defined by population estimates of adults aged 18-64 from the 2018 American Community Survey (ACS) 5-year data, with probabilities proportional to the size measure (PPS) after stratifying by nine Census divisions. In the second stage, 16 secondary sampling units (SSUs), defined by census block groups, were selected with PPS within each PSU. In the third stage, address-based sampling (ABS) was used to randomly select residential addresses within the sampled SSUs from the sampling frame that is based on the U.S. Postal Service Computerized Delivery Sequence File (American Association for Public Opinion Research [AAPOR], 2016a). Each sampled household received a letter detailing the study with the option to complete the roster via web, telephone, or mail. After the households were rostered, up to two individuals between the ages of 18 and 65 were randomly chosen for subsequent screening interviews. Finally, individuals who completed the screening interviews were randomly selected for the clinical interviews via stratified sampling based on their screening responses. Overall, 234,270 households were initially selected, of which 25,752 were rostered (with a weighted response rate of around 20%) and 41,868 individuals from those rostered households were selected for the screening interview. Among them, 29,084 completed the screening interview and 12,906 of those who completed the screening interview were selected for the clinical interview. Eventually, 4,764 individuals residing in residential households completed the clinical interview. Among the non-household populations, 50 prisons were randomly selected from a national list of prisons provided by the Bureau of Justice Statistics using a probability sampling scheme, and 22 agreed to participate. In addition, the study recruited and surveyed four state psychiatric hospitals and 23 homeless shelters as convenience samples. In each facility (prison, hospital, or shelter), a roster of their current individuals was obtained and a random sample of those aged 18 to 65 was selected to complete the clinical interview. Overall, the study completed clinical interviews for 321 prison inmates, 171 patients in the state psychiatric hospitals, and 423 homeless shelter residents, resulting in 5,679 clinical interviews in MDPS after combining with the household sample.
Time Method View help for Time Method
Universe View help for Universe
Unit(s) of Observation View help for Unit(s) of Observation
Data Type(s) View help for Data Type(s)
Mode of Data Collection View help for Mode of Data Collection
HideOriginal Release Date View help for Original Release Date
2024-02-12
Version History View help for Version History
2024-02-12 ICPSR data undergo a confidentiality review and are altered when necessary to limit the risk of disclosure. ICPSR also routinely creates ready-to-go data files along with setups in the major statistical software formats as well as standard codebooks to accompany the data. In addition to these procedures, ICPSR performed the following processing steps for this data collection:
- Created variable labels and/or value labels.
- Checked for undocumented or out-of-range codes.
Notes
The public-use data files in this collection are available for access by the general public. Access does not require affiliation with an ICPSR member institution.
One or more files in this data collection have special restrictions. Restricted data files are not available for direct download from the website; click on the Restricted Data button to learn more.